Cutler Group LP Ligand Pharmaceuticals Inc Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$63.37 - $107.88 $107,729 - $183,396	-1,700 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$96.94 - $113.59 $164,798 - $193,103	1,700 New	1,700 $177,000
Q1 2018 May 11, 2018	SELL	$138.63 - $182.62 $19,962 - $26,297	-144 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$120.91 - $137.94 $17,411 - $19,863	144	144 $19,000

257

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.